Vazzano Joseph Walter 4

What Happened Joseph Walter Vazzano, Chief Financial Officer of Abeona Therapeutics (ABEO), reported a disposition of 1,478 shares on 2026-07-21. The reported per-share price was $6.53, for a total value of about $9,651. The filing indicates these shares were withheld to satisfy tax withholding obligations upon the vesting of restricted stock awards, rather than an opportunistic open‑market sell for cash.

Key Details

• Transaction date: 2026-07-21; reported (filed) 2026-07-22.
• Transaction type: Reported as a sale (S) of 1,478 shares at $6.53 each; total ≈ $9,651.
• Footnote: F1 — shares were withheld to satisfy tax withholding on vesting of restricted stock awards.
• Shares owned after the transaction: not specified in the provided excerpt; see the full Form 4 for post-transaction beneficial ownership.
• Filing timeliness: filed one day after the transaction, which appears timely under Form 4 rules (generally two business days).

Context This transaction reflects tax withholding related to vested restricted stock rather than an active decision to sell shares for investment reasons. Such "sell-to-cover" or withholding transactions are common when equity awards vest and do not necessarily indicate the insider's view of the company's prospects. Retail investors should consult the full Form 4 for exact post-transaction holdings and any other concurrent insider activity.